Nodal marginal zone lymphoma (NMZL) is a rare, indolent B-cell tumor that is distinguished from splenic marginal zone lymphoma (SMZL) by the different pattern of dissemination. NMZL still lacks distinct markers and remains orphan of specific cancer gene lesions. By combining whole-exome sequencing, targeted sequencing of tumor-related genes, whole-transcriptome sequencing, and high-resolution single nucleotide polymorphism array analysis, we aimed at disclosing the pathways that are molecularly deregulated in NMZL and we compare the molecular profile of NMZL with that of SMZL. These analyses identified a distinctive pattern of nonsilent somatic lesions in NMZL. In 35 NMZL patients, 41 genes were found recurrently affected in ≥3 (9%) cases, including highly prevalent molecular lesions of MLL2 (also known as KMT2D; 34%), PTPRD (20%), NOTCH2 (20%), and KLF2 (17%). Mutations of PTPRD, a receptor-type protein tyrosine phosphatase regulating cell growth, were enriched in NMZL across mature B-cell tumors, functionally caused the loss of the phosphatase activity of PTPRD, and were associated with cell-cycle transcriptional program deregulation and increased proliferation index in NMZL. Although NMZL shared with SMZL a common mutation profile, NMZL harbored PTPRD lesions that were otherwise absent in SMZL. Collectively, these findings provide new insights into the genetics of NMZL, identify PTPRD lesions as a novel marker for this lymphoma across mature B-cell tumors, and support the distinction of NMZL as an independent clinicopathologic entity within the current lymphoma classification.

The genetics of nodal marginal zone lymphoma / Spina, Vincenzo; Khiabanian, H; Messina, M; Monti, S; Cascione, L; Bruscaggin, A; Spaccarotella, E; Holmes, Ab; Arcaini, L; Lucioni, M; Tabbò, F; Zairis, S; Diop, F; Cerri, M; Chiaretti, S; Marasca, Roberto; Ponzoni, Martina; Deaglio, S; Ramponi, A; Tiacci, E; Pasqualucci, L; Paulli, M; Falini, Brunangelo; Inghirami, G; Bertoni, Francesco; Foà, R; Rabadan, R; Gaidano, G; Rossi, D.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 128(10):(2016), pp. 1362-1373. [10.1182/blood-2016-02-696757]

The genetics of nodal marginal zone lymphoma

SPINA, VINCENZO;MARASCA, Roberto;PONZONI, MARTINA;FALINI, BRUNANGELO;BERTONI, Francesco;
2016

Abstract

Nodal marginal zone lymphoma (NMZL) is a rare, indolent B-cell tumor that is distinguished from splenic marginal zone lymphoma (SMZL) by the different pattern of dissemination. NMZL still lacks distinct markers and remains orphan of specific cancer gene lesions. By combining whole-exome sequencing, targeted sequencing of tumor-related genes, whole-transcriptome sequencing, and high-resolution single nucleotide polymorphism array analysis, we aimed at disclosing the pathways that are molecularly deregulated in NMZL and we compare the molecular profile of NMZL with that of SMZL. These analyses identified a distinctive pattern of nonsilent somatic lesions in NMZL. In 35 NMZL patients, 41 genes were found recurrently affected in ≥3 (9%) cases, including highly prevalent molecular lesions of MLL2 (also known as KMT2D; 34%), PTPRD (20%), NOTCH2 (20%), and KLF2 (17%). Mutations of PTPRD, a receptor-type protein tyrosine phosphatase regulating cell growth, were enriched in NMZL across mature B-cell tumors, functionally caused the loss of the phosphatase activity of PTPRD, and were associated with cell-cycle transcriptional program deregulation and increased proliferation index in NMZL. Although NMZL shared with SMZL a common mutation profile, NMZL harbored PTPRD lesions that were otherwise absent in SMZL. Collectively, these findings provide new insights into the genetics of NMZL, identify PTPRD lesions as a novel marker for this lymphoma across mature B-cell tumors, and support the distinction of NMZL as an independent clinicopathologic entity within the current lymphoma classification.
22-giu-2016
128(10)
1362
1373
The genetics of nodal marginal zone lymphoma / Spina, Vincenzo; Khiabanian, H; Messina, M; Monti, S; Cascione, L; Bruscaggin, A; Spaccarotella, E; Holmes, Ab; Arcaini, L; Lucioni, M; Tabbò, F; Zairis, S; Diop, F; Cerri, M; Chiaretti, S; Marasca, Roberto; Ponzoni, Martina; Deaglio, S; Ramponi, A; Tiacci, E; Pasqualucci, L; Paulli, M; Falini, Brunangelo; Inghirami, G; Bertoni, Francesco; Foà, R; Rabadan, R; Gaidano, G; Rossi, D.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 128(10):(2016), pp. 1362-1373. [10.1182/blood-2016-02-696757]
Spina, Vincenzo; Khiabanian, H; Messina, M; Monti, S; Cascione, L; Bruscaggin, A; Spaccarotella, E; Holmes, Ab; Arcaini, L; Lucioni, M; Tabbò, F; Zairis, S; Diop, F; Cerri, M; Chiaretti, S; Marasca, Roberto; Ponzoni, Martina; Deaglio, S; Ramponi, A; Tiacci, E; Pasqualucci, L; Paulli, M; Falini, Brunangelo; Inghirami, G; Bertoni, Francesco; Foà, R; Rabadan, R; Gaidano, G; Rossi, D.
File in questo prodotto:
File Dimensione Formato  
spina blood 2016 (genetic NMZL).pdf

non disponibili

Descrizione: lavoro in stampa
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 1.67 MB
Formato Adobe PDF
1.67 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1112424
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 91
  • ???jsp.display-item.citation.isi??? 80
social impact